Are literature references sufficient for dose recommendations? An FDA case study of efavirenz and rifampin.
Saved in:
| Title: | Are literature references sufficient for dose recommendations? An FDA case study of efavirenz and rifampin. |
|---|---|
| Authors: | DiGiacinto JL; Office of Clinica Pharmacology, Division IV, US Food and Drug Administration, Silver Spring, MD, USA., Chan-Tack KM, Robertson SM, Reynolds KS, Struble KA |
| Source: | Journal of clinical pharmacology [J Clin Pharmacol] 2008 Apr; Vol. 48 (4), pp. 518-23. Date of Electronic Publication: 2008 Feb 26. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Wiley Country of Publication: England NLM ID: 0366372 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0091-2700 (Print) Linking ISSN: 00912700 NLM ISO Abbreviation: J Clin Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 18303126 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Are literature references sufficient for dose recommendations? An FDA case study of efavirenz and rifampin. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22DiGiacinto+JL%22">DiGiacinto JL</searchLink>; Office of Clinica Pharmacology, Division IV, US Food and Drug Administration, Silver Spring, MD, USA.<br /><searchLink fieldCode="AU" term="%22Chan-Tack+KM%22">Chan-Tack KM</searchLink><br /><searchLink fieldCode="AU" term="%22Robertson+SM%22">Robertson SM</searchLink><br /><searchLink fieldCode="AU" term="%22Reynolds+KS%22">Reynolds KS</searchLink><br /><searchLink fieldCode="AU" term="%22Struble+KA%22">Struble KA</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220366372%22">Journal of clinical pharmacology</searchLink> [J Clin Pharmacol] 2008 Apr; Vol. 48 (4), pp. 518-23. <i>Date of Electronic Publication: </i>2008 Feb 26. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0366372 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>0091-2700 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200912700%22">00912700 </searchLink><i>NLM ISO Abbreviation: </i>J Clin Pharmacol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=18303126 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1177/0091270008315308 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 518 Titles: – TitleFull: Are literature references sufficient for dose recommendations? An FDA case study of efavirenz and rifampin. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: DiGiacinto JL – PersonEntity: Name: NameFull: Chan-Tack KM – PersonEntity: Name: NameFull: Robertson SM – PersonEntity: Name: NameFull: Reynolds KS – PersonEntity: Name: NameFull: Struble KA IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: 2008 Apr Type: published Y: 2008 Identifiers: – Type: issn-print Value: 0091-2700 Numbering: – Type: volume Value: 48 – Type: issue Value: 4 Titles: – TitleFull: Journal of clinical pharmacology Type: main |
| ResultId | 1 |